Einloggen
Ausschreibungen
Contact us
21 01 88 60
Deutschland
Danmark
Deutschland
Eesti
Latvija
Lietuva
Norge
Polska
Russia
Suomi
Sverige
World
UK & Ireland
USA
Nederland
България
Deutschland
Danmark
Deutschland
Eesti
Latvija
Lietuva
Norge
Polska
Russia
Suomi
Sverige
World
UK & Ireland
USA
Nederland
България
Contact us
Einloggen
Toggle navigation
Hilfebereich
Über uns
Kontakt mit uns auf
Abteilungen
Mercell Trust Center
Ethische Werte
Investoreninformationen
Ausschreibungsberatung
Ausschreibungsangebot
Ausschreibungsangebot
Verfahren und Preise
ESPD
Website
Tenders
Intensjonskunngjøring: 2501b - Buccolam munnvann ATC: N05CD08
Information
Notice type
 
Tender type
eForm 25 Voluntary ex-ante transparency notice
Procedure
Negotiated procedure without prior call for competition
Estimated tendering starting date
Estimated tendering closing date
Publication date
01.07.2024 09:06 (GMT+02:00)
Closing date
Questions closing date
Recommended document due date
Accepts parallel bids
No
Accepts variant bids
No
Buyer
Name
SYKEHUSINNKJØP HF
SYKEHUSINNKJØP HF
Department
Contact
Camilla Hanstvedt
Camilla Hanstvedt
Address
Postboks 40
Tollbugata 7
9811
VADSØ
Norwegen
Org. number
916879067
Website
www.sykehusinnkjop.no
Short description
Intensjon om å inngå direkteavtale av Buccolam munnvann, ATC N05CD08 fra Nauroxpharm AB. Se nærmere beskrivelse.
Files (click "Show interest" to get access)
Name
Size
2501b Avtale - Rammeavtale legemidler ikke inj inf.pdf
378 KB
2501b Bilag 2 Prisskjema.xlsx
1,18 MB
2501b Bilag 3 Kravspesifikasjon legemidler ikke inj inf v2.xlsx
125 KB
2501b Bilag 4 Administrative bestemmelser.docx
157 KB
Mercell Germany
Part of the Mercell Group, one of Europe’s leading providers of e tender systems and information between buyers and suppliers in the professional market.
Our producs
Tender offer
ESPD
Tender consulting
E tender system
About us
The company
Departments
Ethical guidelines
Investor information
Career
Contact us
Write to us
+47 21 01 88 60
Mercell Germany
|
Askekroken 11
,
0277
OSLO
,
Norwegen
Cookie info
|
Contact us
|
Einloggen